The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Dalton Mark F since 2008.
The trader's CIK number is 1250267.
At the time of the last reporting, Dalton Mark F was the Director of Progenics Pharmaceuticals Inc. (stock ticker symbol PGNX).
Also see all insider trading activities at Progenics Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | PGNX | 0 | $0 | 0 | $0 | 7,500 | $40,222 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-05-14 | PGNX | Option Ex | 7,500 | 5.36 | 40,222 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dalton Mark F (Director of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.